Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Revolution Medicines Inc (RVMD)

515 + Investors. Track Smart Money conviction in RVMD. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +132
Streak
11Q ▲
Buyers last Q
66%

Smart Money Signals — RVMD

Based on 518 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 11 quarters in a row

last 6Q
For 11 consecutive quarters, more hedge funds added RVMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
518 hedge funds hold RVMD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +85% more funds vs a year ago

fund count last 6Q
+238 new funds entered over the past year (+85% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 66% buying

344 buying176 selling
Last quarter: 344 funds were net buyers (172 opened a brand new position + 172 added to an existing one). Only 176 were sellers (136 trimmed + 40 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+64 vs last Q)

new funds entering per quarter
Funds opening a new RVMD position: 60 → 62 → 108 → 172. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 31% long-term, 45% new

■ 31% conviction (2yr+) ■ 24% medium ■ 45% new
Of the 518 current holders: 161 (31%) held >2 years, 123 held 1–2 years, and 234 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +23% but shares only +3% — price-driven

Value
+22%
Shares
+2%
Last quarter: the total dollar value of institutional holdings rose +23%, but actual share count only changed +3%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

50 → 60 → 62 → 108 → 172 new funds/Q
New funds entering each quarter: 60 → 62 → 108 → 172. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 40% veterans vs 47% newcomers

■ 40% veterans ■ 13% 1-2yr ■ 47% new
Entry-cohort mix of 557 holders: 224 (40%) are 2+ year veterans, 70 entered 1–2 years ago, and 263 (47%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 36% AUM from major funds

36% from top-100 AUM funds
61 of 511 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.1
out of 10
Moderate Exit Risk
Exit risk score 5.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RVMD

In 2026 Q1, 344 hedge funds were net buyers of RVMD (172 opened a new position, 172 added to an existing one), while 176 reduced or exited (136 trimmed, 40 sold completely) — a 66% buyer ratio, indicating clear institutional accumulation. This marks 11 consecutive quarters of net institutional buying — a persistent conviction signal. 36% of total institutional value in RVMD is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +132 funds (more new holders than closures). Total institutional holders: 518.

Hedge Fund Ownership: RVMD

How many hedge funds hold RVMD — quarterly history vs. share price
Quarterly hedge fund ownership of RVMD vs. share price

Market Analysis: RVMD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RVMD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Growing Institutional Interest

Quality funds are building positions — conviction is rising but not yet widespread.

38 top-rated funds 26 high-conviction
Consensus
6.9
/ 10
breadth
×
Elite
6.5
/ 10
conviction
Hedge Fund Positioning: RVMD
2026 Q2 Stats Unlock in 2 days 515 + Investors

Track Smart Money conviction in RVMD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 515 385 33.77%
13F Shares 206M 203M 1.83%
Total Value $19.32B $15.81B 22.19%
New Positions 171 108 +63
Increased Positions 169 134 +35
Closed Positions 41 40 +1
Reduced Positions 126 101 +25
Total Calls 20 10 100.0%
Total Puts 26 8 225.0%
PUT/CALL Ratio 1.3 0.8 Bearish

Statistics: RVMD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

515 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RVMD. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 RVMD holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Nextech Invest Ltd. 67.55% 7,601,087 $1.42B
2 AIHC Capital Management Ltd 54.46% 303,133 $56.8M
3 Darwin Global Management, Ltd. 54.45% 10,629,822 $2.05B
4 MIC Capital Management UK LLP 25.25% 531,733 $99.6M
5 Casdin Capital, LLC 24.16% 2,577,333 $482.7M
6 Paradigm Biocapital Advisors LP 22.31% 6,361,323 $1.19B
7 DAFNA Capital Management LLC 20.09% 562,630 $105.4M
8 Checkpoint Capital L.P. 19.72% 410,353 $76.9M
9 Mass General Brigham, Inc 17.85% 344,091 $64.4M
10 Caligan Partners LP 17.28% 1,961,795 $367.4M
11 Bvf Inc/Il 14.20% 2,965,160 $555.3M
12 Integral Health Asset Management, LLC 11.10% 1,500,000 $280.9M
13 Baker BROS. Advisors LP 10.74% 11,443,357 $2.14B
14 Rock Springs Capital Management LP 10.10% 1,105,210 $207.0M
15 First Turn Management, LLC 8.32% 415,307 $77.8M
16 Patient Square Capital LP 8.01% 276,000 $51.7M
17 Seven Fleet Capital Management LP 7.48% 242,029 $45.3M
18 Boxer Capital Management, LLC 7.05% 500,000 $93.6M
19 Nearwater Capital Markets, Ltd 6.77% 2,097,000 $392.7M
20 Artia Global Partners LP 6.41% 185,390 $34.7M
21 Superstring Capital Management LP 6.04% 51,053 $9.6M
22 Logos Global Management LP 5.64% 700,000 $131.1M
23 MPM BioImpact LLC 5.62% 492,483 $92.2M
24 Stempoint Capital LP 5.16% 159,943 $30.0M
25 Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.91% 479,080 $89.7M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Revolution Medicines Inc (RVMD)

What does the Smart Money Trend signal show for RVMD?

Buying streak — 11 quarters in a row: For 11 consecutive quarters, more hedge funds added RVMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RVMD?

More buyers than sellers — 66% buying: Last quarter: 344 funds were net buyers (172 opened a brand new position + 172 added to an existing one). Only 176 were sellers (136 trimmed + 40 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RVMD holders?

Strong quality — 36% AUM from major funds: 61 of 511 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held RVMD?

Mixed — 31% long-term, 45% new: Of the 518 current holders: 161 (31%) held >2 years, 123 held 1–2 years, and 234 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →